PharmTech Drug Digest 11.20
|Articles|September 2, 2009

Pharmaceutical Technology

  • Pharmaceutical Technology-09-02-2009
  • Volume 33
  • Issue 9

Pharmaceutical Technology, September 2009 Issue (PDF)

Robots Lend a Hand

Articles in this issue

about 17 years ago

Pharma Capsules

about 17 years ago

Of Audits and Gunk

about 17 years ago

Quality by Enforcement

about 17 years ago

It's Easy Being Green

about 17 years ago

Expansion Plan

about 17 years ago

In the Spotlight September 2009

about 17 years ago

Pill-Level Product Protection

Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.